Jane Liesveld is a Hematology physician affiliated with University of Rochester Medical Center. OpenAlex indexes 438 publications with 14,735 citations (h-index 63); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
601 Elmwood Ave
Box Med
Rochester, NY 146420001
Telephone
585-275-0784Registry record last updated 30 Jun 2023.
Clinical trials
- Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients
Sponsor: University of Rochester
- Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation
Sponsor: Jane Liesveld
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- National Marrow Donor ProgramProgram year20252 payments
- Merck Sharp & Dohme LLCProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
41.2%Kinase inhibitor22.9%Jakafi61%Imatinib Mesylate22%Calquence17%Part D<11 patientsThalidomide Analog4.9%Lenalidomide100%Part D<11 patients+ 4 more classes in this area
Anti-infectives
21%Azole Antifungal10.3%Fluconazole82%Voriconazole18%Part D<11 patientsShort-acting sulfonamides6.2%Sulfamethoxazole-Trimethoprim100%Part D≥17 patients+ 2 more classes in this area
Metabolism & gastrointestinal
14.8%Proton pump inhibitor7%Pantoprazole Sodium77%Omeprazole23%Part D<11 patientsCorticosteroid4.1%Prednisone100%Part D≥15 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 1990–2026 per NIH RePORTER. The latest:
- Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis
University of Rochester
FY2026$534,854R01AG079556 - Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis
University of Rochester
FY2025$524,156R01AG079556 - Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesis
University of Rochester
FY2024$534,854R01AG079556
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Ann Falsey, MD
University of Rochester Medical Center
Louis Constine, MD
University of Rochester Medical Center
Supriya Mohile, MD
University of Rochester Medical Center
Edward Messing, MD
University of Rochester Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”